| Date Filed | Type | Description |
| 02/27/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 02/14/2023 |
SC 13G
| GLAZER CAPITAL, LLC reports a 9.7% stake in Medicus Sciences Acquisition Corporation |
| 02/14/2023 |
SC 13G
| First Trust Capital Management L.P. reports a 7.3% stake in Medicus Sciences Acquisition Corp. |
| 02/13/2023 |
8-K
| Quarterly results |
| 02/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/24/2023 |
SC 13G/A
| Cowen Financial Products LLC reports a 0% stake in Medicus Sciences Acquisition Corp. |
| 01/18/2023 |
8-K
| Quarterly results |
| 08/11/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 05/12/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 03/28/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/11/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/15/2022 |
8-K
| Regulation FD Disclosure Interactive Data |
| 02/14/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2022 |
SC 13G
| Medicus Sciences Holdings LLC reports a 20% stake in Medicus Sciences Acquisition Corp. |
| 02/14/2022 |
SC 13G/A
| HealthCor Management, L.P. reports a 0% stake in Medicus Sciences Acquisition Corp |
| 02/14/2022 |
SC 13G/A
| Saba Capital Management, L.P. reports a 8.8% stake in Medicus Sciences Acquisition Corp |
| 02/08/2022 |
8-K
| Quarterly results |
| 01/20/2022 |
10-Q/A
| Quarterly Report for the period ended September 30, 2021 [amend] |
| 01/18/2022 |
SC 13G
| D. E. SHAW & CO, L.P. reports a 5.7% stake in Medicus Sciences Acquisition Corp. |
| 12/06/2021 |
8-K
| Quarterly results |
| 11/04/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 08/05/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 08/05/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/24/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 05/17/2021 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 04/06/2021 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 04/01/2021 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"Medicus Sciences Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing April 5, 2021 New York, April 1, 2021 // -- Medicus Sciences Acquisition Corp. announced that, commencing April 5, 2021 , the units sold in the Company’ s initial public offering will no longer trade, and that the Company’ s Class A ordinary shares and the Company’ s redeemable warrants which together comprise the Units will commence trading separately. The Class A Ordinary Shares and the Redeemable Warrants will be listed on the Nasdaq Capital Market and trade under the ticker symbols, “MSAC” and “MSACW,” respectively. This is a mandatory and automatic separation, and no action is required by the holders of the Units. Each of the 92,000,000 Units sold in MSAC’ s initia..." |
|
| 03/31/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 03/01/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/26/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/24/2021 |
8-K
| Quarterly results |
| 02/19/2021 |
8-K
| Quarterly results |
| 02/17/2021 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
| 02/16/2021 |
CERT
| Form CERT - Certification by an exchange approving securities for listing: |
|